Cover Image
市場調查報告書

美國的質子治療市場預測

US Proton Therapy Market Forecast to 2022

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 282154
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的質子治療市場預測 US Proton Therapy Market Forecast to 2022
出版日期: 內容資訊: 英文 35 Pages
簡介

美國的質子治療市場,至2020年收益達到約12億2,000萬美元,預計2014年∼2020年以11.4%的年複合成長率成長。

本報告提供美國的質子治療市場相關調查分析、市場現況與展望、主要趨勢、推動因素與阻礙因素、競爭情形與策略性分析等系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 美國的癌症人口統計

  • 發病率:各州
  • 發病率:各部位

第4章 目前放射治療

  • 三度空間順形放射治療 (3D-CRT)
  • 影像導航放射治療 (IGRT)
  • 強度調控放射治療 (IMRT)
  • 立體定位放射線治療 (STRT)
  • 中子治療
  • 質子治療

第5章 標準的質子治療中心的結構要素

  • 質子加速器
  • 射束傳輸系統
  • 射束傳送系統
  • 管嘴
  • 治療計劃系統
  • 影像瀏覽器
  • 病患定位系統
  • 人力資源

第6章 美國的質子治療市場預測

  • 目前市場規模與未來成長
  • 潛在患者數:各州
  • 現有、未來參與企業分析
  • 機會的評估

第7章 市場趨勢

  • 有許多治療室的中心增加
  • 小型的質子加速器開始普及

第8章 產業的推動因素與阻礙因素

  • 推動因素
  • 阻礙因素

第9章 競爭情形與策略性分析

  • IBA Group
  • 日立製作所
  • Mevion Medical Systems
  • Varian

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

In light of an alarmingly rising incidence of cancers and limited treatment options, physicians are being forced to look beyond conventional treatments. In such a scenario, Proton Therapy, the most advanced radiation technique available, is being projected as the Rolls Royce of Radiation Oncology. Unfortunately, access to proton therapy is limited for many patients due to a low number of proton therapy centers. Hence, many research institutions and hospitals have started investing in proton therapy to make it more accessible to patients.

According to the "US Proton Therapy Market Outlook 2020", report by RNCOS, the United States will be home to 29 such centers by 2020. Consequently, the market will breach a Billion dollar mark to attain revenue of around US$ 1.22 Billion by 2020, growing at a CAGR of 11.4% during the forecast period (2014-2020). The report provides an insight into the cancer demographics of USA and the various possible causes for a high cancer incidence in the country. The document covers a historical trend (2008-2014) of cancer incidences, deaths and prevalence along with state-wide and site-wide cancer incidences in the country.

Based on a complex correlation-regression model accounting population demographics, disease statistics, macro & micro economic indicators of the country, etc., we have performed an opportunity assessment for the potential of proton therapy in the US. We have been able to draw the current and future demands for a number of proton therapy centers in the country. Not only this, the report enlists the top ten states with the maximum potential for a proton therapy center. The list provides an insight into the current and future scenarios of centers along with an estimation of the shortage of proton centers in each state which can help service providers and vendors to extract benefits from the largely untapped but lucrative market.

As for the market, the report provides a state-wide distribution of proton therapy centers in the US. A thorough analysis has been done on the existing and upcoming proton therapy centers to measure the market size and its future condition.

Following that, RNCOS was able to deduce various trends, drivers and challenges which would have a major influence in shaping the growing market. On the competitive front, the report covers the current stand of the market and its probable transformation by 2020 for service providers and equipment vendors. There is also a 'strengths-weakness' analysis of equipment vendors along with their business overviews, products & services, and existing & planned installations in US till 2020, thus making it a must read for consultants and companies planning to enter the market.

Table of Contents

1. Analyst View

2. Research Methodology

3. US Cancer Demographics

  • 3.1 Incidence by State
  • 3.2 Incidence by Site

4. Current Radiation Therapies

  • 4.1 Third Dimensional Conformal Therapy (CRT)
  • 4.2 Image Guided Radiotherapy (IGRT)
  • 4.3 Intensity Modulated Radiotherapy (IMRT)
  • 4.4 Stereotactic Radiotherapy
  • 4.5 Neutron Therapy
  • 4.6 Proton Therapy
    • 4.6.1 Why Proton Therapy?

5. Components of a Standard Proton Therapy Center

  • 5.1 Proton Accelerator
  • 5.2 Beam Transport System
  • 5.3 Beam Delivery System
  • 5.4 Nozzle
    • 5.4.1 Single Scattering
    • 5.4.2 Double Scattering
    • 5.4.3 Uniform Scanning Nozzle
    • 5.4.4 Pencil Scanning Nozzle
  • 5.5 Treatment Planning System
  • 5.6 Image Viewers
  • 5.7 Patient Positioning System
  • 5.8 Human Resource

6. US Proton Therapy Market Outlook to 2018

  • 6.1 Current Market Size and Future Growth
  • 6.2 Potential Patients by State (2014 & 2020)
    • 6.2.1 Market Penetration
  • 6.3 Analysis of Existing and Forthcoming Players
    • 6.3.1 Service Providers
    • 6.3.2 Equipment Providers
  • 6.4 Opportunity Assessment

7. Market Trends

  • 7.1 Increasing Centers with More Number of Treatment Rooms
  • 7.2 Penetration of Smaller Proton Accelerators Increasing

8. Industry Drivers and Restraints

  • 8.1 Drivers
    • 8.1.1 Increasing Incidence of Cancer
    • 8.1.2 Benefits over Conventional Therapies
  • 8.2 Restraints
    • 8.2.1 Reimbursement Issues
    • 8.2.2 High Prices

9. Competitive Landscape and Strategic Analysis

  • 9.1 IBA Group
  • 9.2 Hitachi
  • 9.3 Mevion Medical Systems
  • 9.4 Varian

List of Figures:

  • Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
  • Figure 5-1: Components of a Proton Therapy Center
  • Figure 6-1: Proton Therapy Market (Million US$), 2014-2020
  • Figure 6-2: Share of Proton Therapy Market in Potential Market (2014)
  • Figure 6-3: Share of Proton Therapy Market in Potential Market (2020)
  • Figure 6-4: Market Share of Service Providers (2014)
  • Figure 6-5: Market Share of Service Providers (2020)
  • Figure 6-6: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2014)
  • Figure 6-7: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2020)
  • Figure 6-8: Demand of Proton Therapy Centers (2014 & 2020)
  • Figure 6-9: Shortage of Proton Therapy Centers (2014 & 2020)
  • Figure 7-1: Proton Therapy Center by Number of Treatment Rooms (2014 & 2020)
  • Figure 7-2: Proton Therapy Center by Type of Proton Accelerator (2014 & 2020)
  • Figure 8-1: Cancer Incidence (Million), 2008-2014
  • Figure 8-2: Cancer Mortality ('000), 2008-2014
  • Figure 9-1: IBA: Breakdown of Revenue by Activity (2014)

List of Tables:

  • Table 3-1: Cancer Incidence by State (Million), 2008-2014
  • Table 3-2: Cancer Incidence by Site (Million), 2008-2014
  • Table 6-1: State-wide Potential Patients for Proton Therapy (2014)
  • Table 6-2: State-wide Potential Patients for Proton Therapy (2020)
  • Table 6-3: Proton Therapy Centers (2014)
  • Table 6-4: Upcoming Proton Therapy Centers (2015 to 2019)
  • Table 6-5: Proton Therapy Equipment Providers with number of Installations till 2014
  • Table 6-6: Proton Therapy Equipment Providers with Number of Installations by 2020
  • Table 6-7: Shortage of Proton Therapy Centers (2020)
  • Table 9-1: IBA - Proton Therapy Products and Services
  • Table 9-2: IBA - Key Financials (Million Euro), 2012-2014
  • Table 9-3: IBA - Existing and Upcoming Proton Therapy Installations
  • Table 9-4: IBA - Strengths and Weaknesses
  • Table 9-5: Hitachi - Key Financials (Billion US$), 2012-2014
  • Table 9-6: Hitachi - Existing and Upcoming Proton Therapy Installations
  • Table 9-7: Hitachi - Strengths and Weaknesses
  • Table 9-8: Mevion - Existing and Upcoming Proton Therapy Installations
  • Table 9-9: Mevion - Strengths and Weaknesses
  • Table 9-10: Varian - Proton Therapy Products and Services
  • Table 9-11: Varian - Key Financials (Billion US$), 2012-2014
  • Table 9-12: Varian: Proton Therapy Installations
  • Table 9-13: Varian - Strengths and Weaknesses
Back to Top